SEC Form 4 · accession 0001179110-16-032655
MEDICINES CO /DE · MDCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher T Cox
Officer — EVP & Chief Corp. Dev. Officer
Period of report
Dec 7, 2016
Accepted (ET)
Dec 9, 2016 · 11:37 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113481
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Dec 7, 2016 | P | 89,000 | $33.33 | A | 154,655 | I | See footnote |
| Common StockF3,F2 | Dec 8, 2016 | P | 16,500 | $32.52 | A | 171,155 | I | See footnote |
| Common Stock | holding | — | — | — | 33,670 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the weighted average purchase price of the shares purchased ranging from a low of $32.73 to a high of $33.49 per share. The reporting person undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price for this footnote (1) and footnote (3).
- F2The reporting person holds a power of attorney with respect to this account. Members of the reporting person's immediate family may be considered to have a pecuniary interest in this account. The reporting person disclaims beneficial ownership of the shares held by this account except to the extent of his pecuniary interest therein.
- F3Represents the weighted average purchase price of the shares purchased ranging from a low of $32.13 to a high of $32.87 per share.